Food allergies are a major public health concern, with rising rates in both developed and developing countries. For example, according to Food Allergy Research and Education's 2022 statistics, around 2.8 million Americans are predicted to have an egg allergy in 2020, and 2.5 million will have a wheat allergy. Thus, the increased prevalence of various allergy disorders among the population raises the necessity for early detection and identification of allergens, which is likely to raise the demand for effective diagnostic tests or systems, propelling market expansion.
Data Bridge Market Research analyses that the Allergy Diagnostics Market which is USD 276.32 billion in 2022, is expected to reach USD 558.72 billion by 2030, at a CAGR of 9.2% during the forecast period 2023 to 2030.
“Growing number of research and development activities is bolstering the market growth”
The increased emphasis of companies on R&D operations to develop novel diagnostic products, tests, or kits to meet high unmet medical requirements is having a significant impact on market growth. For example, Omega Diagnostics got permission from the China National Medical Products Administration (NMPA) in November 2020 for Omega's food detective test in China. In addition, HYCOR Biomedical and Changsha Haike Biotechnology Co., Ltd. filed their ALLEOS 2000 allergy testing system with the China Hunan Medical Products Administration (HMPA) in August 2020.
What restraints the growth of the Middle East and North Africa Allergy Diagnostics Market?
“Premium costs associated will restrain the market growth"
Market participants frequently update allergy diagnostic instruments such as luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers. These instruments are more expensive since they have more advanced features and functions (the price of each instrument varies depending on its accuracy, flexibility, and TAT). Immunoassay analyzers, for example, range in price from $10,000 to $20,000, while luminometers range from $3,000 to $14,000. Semi-automated ELISA readers cost between $2,000 and $5,000, whereas fully automated analyzers cost more than $14,000. Furthermore, maintaining and insuring this equipment, as well as laboratory supervision and overheads (such as utilities, space, and administration), incur additional costs.
Segmentation: Middle East and North Africa Allergy Diagnostics Market
The allergy diagnostics is segmented on the basis of products and services, allergan, test, end-user and distribution channel.
- Based on product and services, the market is segmented into assay kits, instruments, consumables and services.
- On the basis of allergen, the market is segmented into inhaled allergens, food allergens, antibiotics, other drugs and chemicals allergens, occupational allergens, miscellaneous plant allergens, contact allergens and others.
- Based on test, the market is segmented into in-vitro test and in-vivo test.
- Based on end user, the market is segmented into hospital-based laboratories, diagnostic laboratories, academic research laboratories and others.
- Based on distribution channel, the market is segmented into direct and indirect.
Regional Insights: Saudi Arabia dominates the Middle East and North Africa allergy diagnostics market
Since Saudi is the leader in allergy diagnostics production and exports main component parts necessary for allergy diagnostics, Saudi Arabia leads the industry. Omega Diagnostics Group PLC, for example, will be the market leader in 2030, with a market share of approximately 26.63%.
To know more about the study, visit, https://www.databridgemarketresearch.com/de/reports/middle-east-and-north-africa-allergy-diagnostics-market
The Prominent Key Players Operating in the Middle East and North Africa Allergy Diagnostics Market Include:
- Thermo Fisher Scientific Inc. (U.S.)
- Siemens Healthcare GmbH (Germany)
- Danaher (U.S.)
- Omega Diagnostics Group PLC (U.K.)
- BIOMÉRIEUX (France)
- Romer Labs Division Holding (Austria)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- HollisterStier Allergy (U.S.)
- NEOGEN Corporation (U.S.)
- Eurofins Scientific (Luxembourg)
- Minaris Medical America, Inc. (U.S.)
- Stallergenes Greer (U.K.)
- HOB Biotech Group Corp., Ltd. (China)
- HYCOR Biomedical (U.S.)
- R-Biopharm AG (Germany)
- AESKU GROUP GmbH (Germany)
- ACON Laboratories, Inc. (U.S.)
- Lincoln Diagnostics, Inc. (U.S.)
- Astra Biotech GmbH (Germany)
- Erba Group (U.K.)
Above are the key players covered in the report, to know about more and exhaustive list of Middle East and North Africa allergy diagnostics market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Middle East and North Africa Allergy Diagnostics Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
